Clinical Trial Update: Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating autologous tumor-infiltrating lymphocytes in pediatric, adolescent, and young adult participants with soft tissue sarcoma, primary cent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Carcinoma
• Ewing Sarcoma
• Melanoma
• Rhabdomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Lifileucel (autologous tumor-infiltrating lymphocytes (TIL) therapy)

Snippet

Sponsor: Iovance Biotherapeutics, Inc. | Conditions: Soft Tissue Sarcoma, Primary Central Nervous System Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING